15078907

Source:http://linkedlifedata.com/resource/pubmed/id/15078907

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005684, umls-concept:C0087111, umls-concept:C0376515, umls-concept:C0456603, umls-concept:C0600558, umls-concept:C0918012, umls-concept:C1559154, umls-concept:C2698872
pubmed:issue	3
pubmed:dateCreated	2004-4-13
pubmed:abstractText	In this study, locally advanced bladder cancer was treated by radiation combined with cisplatin therapy and a retrospective analysis was conducted to predict the clinical response to chemoradiotherapy (CRT) based on the immunohistochemistry of apoptosis-related proteins.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/BAX protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Ki-67 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0368-2811
pubmed:author	pubmed-author:FukunagaKojiK, pubmed-author:MatsumotoHiroakiH, pubmed-author:MatsuyamaHideyasuH, pubmed-author:NaitoKatsusukeK, pubmed-author:WadaTakashiT, pubmed-author:YoshihiroSatoruS
pubmed:issnType	Print
pubmed:volume	34
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	124-30
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15078907-Aged, pubmed-meshheading:15078907-Aged, 80 and over, pubmed-meshheading:15078907-Antineoplastic Agents, pubmed-meshheading:15078907-Apoptosis, pubmed-meshheading:15078907-Carcinoma, Transitional Cell, pubmed-meshheading:15078907-Cisplatin, pubmed-meshheading:15078907-Female, pubmed-meshheading:15078907-Humans, pubmed-meshheading:15078907-Ki-67 Antigen, pubmed-meshheading:15078907-Male, pubmed-meshheading:15078907-Middle Aged, pubmed-meshheading:15078907-Neoadjuvant Therapy, pubmed-meshheading:15078907-Prognosis, pubmed-meshheading:15078907-Proto-Oncogene Proteins, pubmed-meshheading:15078907-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:15078907-Radiotherapy Dosage, pubmed-meshheading:15078907-Retrospective Studies, pubmed-meshheading:15078907-Survival Rate, pubmed-meshheading:15078907-Tumor Suppressor Protein p53, pubmed-meshheading:15078907-Urinary Bladder Neoplasms, pubmed-meshheading:15078907-bcl-2-Associated X Protein
pubmed:year	2004
pubmed:articleTitle	Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.
pubmed:affiliation	Department of Urology, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan.
pubmed:publicationType	Journal Article